Evidence map›Paper›PMID 30020974›Full record

ArticlePloS one2018

Role of genetic and electrolyte abnormalities in prolonged QTc interval and sudden cardiac death in end-stage renal disease patients.

Monica Coll, Carles Ferrer-Costa, Sara Pich, Catarina Allegue, Emilio Rodrigo, Gema Fernández-Fresnedo, Paloma Barreda, Jesus Mates, Angel Luis Martinez de Francisco, Israel Ortega and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Functional Profiling ofCirculation. Genomic and precision medicine · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. H1153Y-International journal of molecular sciences · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. The ketogenic diet and the QT interval.Proceedings (Baylor University. Medical Center) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Monica CollCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.ORCID 0000-0003-1214-803X
Carles Ferrer-CostaScientific Department, Gendiag.exe., Barcelona, Spain.
Sara PichScientific Department, Gendiag.exe., Barcelona, Spain.
Catarina AllegueCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.
Emilio RodrigoIFIMAV-Servicio de Nefrología del Hospital Universitario Marqués de Valdecilla, Santander, Spain.ORCID 0000-0002-2845-5272
Gema Fernández-FresnedoIFIMAV-Servicio de Nefrología del Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Paloma BarredaIFIMAV-Servicio de Nefrología del Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Jesus MatesCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.
Angel Luis Martinez de FranciscoIFIMAV-Servicio de Nefrología del Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Israel OrtegaScientific Department, Gendiag.exe., Barcelona, Spain.
Anna IglesiasCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.
Oscar CampuzanoCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.ORCID 0000-0001-5298-5276
Eduardo SalasScientific Department, Gendiag.exe., Barcelona, Spain.
Manuel AriasIFIMAV-Servicio de Nefrología del Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Ramon BrugadaCardiovascular Genetics Center, IDIBGI, Dr. Trueta University Hospital, Parc Hospitalari Martí i Julià, Edifici M2, Salt, Spain.
Institut d'Investigació Biomèdica de Girona · ESFundación Marques de Valdecilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with end-stage renal disease have very high mortality. In individuals on hemodialysis, cardiovascular deaths account for ~50% of all deaths in this population, mostly due to arrhythmia. To determine the causes of these arrhythmic deaths is essential in order to adopt preventive strategies. The main objective of this study was to investigate whether, the presence of QTc interval alterations, from electrolyte abnormalities or presence of rare genetic variants, could have a relationship with sudden arrhythmogenic deaths in end-stage renal disease patients.

methodsWe recorded the pre- and post-dialysis QTc interval in 111 patients undergoing hemodialysis. In 47 of them, we analyzed 24 SCD-related genes including the most prevalent genes associated with long QT syndrome using a custom resequencing panel.

resultsWe found a positive although not significant association between the presence of long QTc and mortality in a subset of end-stage renal disease patients. In addition, in five patients with long QTc only after dialysis (21.7%) we detected rare potentially pathogenic genetic variants. Three out of these five carriers subsequently died suddenly.

conclusionsGenetic background may be determinant in the risk of sudden cardiac death in these patients. We recommend evaluating the QTc interval before and after hemodialysis, and performing a genetic analysis of individuals with long QTc after hemodialysis.

Indexed as

AgedArrhythmias, CardiacComputational BiologyDeath, Sudden, CardiacElectrocardiographyElectrolytesFemaleHumansKidney Failure, ChronicLong QT SyndromeMaleMiddle AgedElectrolytes

Identifiers

PMID30020974
PMCPMC6051653
OpenAlexW2884976020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.